C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2004
12/09/2004	WO2004106293A2 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
12/09/2004	WO2004075863A3 Cxcr3 antagonists
12/09/2004	WO2004063151A3 Novel tyrosine kinase inhibitors
12/09/2004	US20040249158 Amine salts of an integrin receptor antagonist
12/09/2004	US20040249147 Reacting an epoxy alcohol with reactants having active hydrogen attached to nitrogen, oxygen or sulfur in the presence of redox coupling agents comprising a reducing agent and an oxidizing agent for producing azole compound
12/09/2004	US20040248929 Process for imidazo[4,5-c]pyridin-4-amines
12/09/2004	US20040248928 Cardiovascular system protection; ischemic attack, reperfusion, cardiac surgery
12/09/2004	US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
12/09/2004	US20040248922 Lavendamycin analogs, quinoline-5,8-diones and methods of using them
12/09/2004	US20040248917 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
12/09/2004	US20040248903 Pyrazolo-pyridine derivatives as antiherpes agents
12/09/2004	US20040248900 Endothelial nitric oxide synthase expression stimulants; cardiovascular disorders
12/09/2004	US20040248898 Group V and/or X secretory phospholipase A2 inhibition; suppressing degeneration of serum lipoproteins
12/09/2004	US20040248890 Voltage gated sodium and calcium channel inhibitors
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	US20040248854 Piperidinyl prostaglandin E analogs
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	CA2527017A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
12/08/2004	EP1484329A1 Indole derivatives with apoptosis inducing activity
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483265A1 Purine derivatives as kinase inhibitors
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483262A1 Coumarines useful as biomarkers
12/08/2004	EP1483259A1 Pyrimidines as novel openers of potassium ion channels
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1381363B1 Imidazo [1,2-a]-pyridine derivatives as mglur5 antagonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1061076B1 N-acyl cyclic amine derivatives
12/08/2004	EP0831094B1 Fused polycyclic heterocycle derivatives
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553911A Pyrrole derivatives, their preparation and their therapeutic uses
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553909A Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
12/08/2004	CN1553906A VARIOLIN derivatives and their use as antitumor agents
12/08/2004	CN1553814A Remedies for arteriosclerosis
12/08/2004	CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines
12/08/2004	CN1552712A New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
12/08/2004	CN1552711A Yageine derivative compounds and their uses
12/08/2004	CN1178991C Method for preparing deep colour perylene dye
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178939C Non-nucleoside reverse transcriptase inhibitors
12/08/2004	CN1178938C 1,2-annelated quinoline derivatives
12/07/2004	US6828342 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment
12/07/2004	US6828329 Aryl fused substituted 4-oxy-pyridines
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828325 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828316 Antiallergens
12/07/2004	US6828159 Carbopyronine fluorescent dyes
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2272136C Pyrazole derivatives having crf antagonist activity
12/07/2004	CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2127374C Novel derivative of isoindolinone, its preparation and pharmaceutical compositions containing it
12/02/2004	WO2004104004A2 Triaza-spiro compounds as nociceptin analogues and uses thereof
12/02/2004	WO2004104003A1 Novel pyridopyrazines and use thereof as kinase modulators
12/02/2004	WO2004104002A1 Novel pyridopyrazines and use thereof as kinase inhibitors
12/02/2004	WO2004104001A2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
12/02/2004	WO2004103305A2 Spiropyrazole compound
12/02/2004	WO2004024074A3 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
12/02/2004	WO2004020584A3 Antagonists of chemokine receptors
12/02/2004	US20040242886 Induction apoptosis in tumor cells; antitumor, anticancer agents
12/02/2004	US20040242866 Tricyclic benzodiazepines as vasopressin receptor antagonists
12/02/2004	US20040242664 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
12/02/2004	US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242623 tricyclic pyridines compounds, e.g., 1-(4-methoxy-2-methylphenyl)-7-methyl-5-(1-propyl-butyl)-1,2,2a, 3,4,5-hexahydro-1,5,8-triaza-acenaphtylene; CRF antagonists used for treatment of depression, anxiety, irritable bowel disease and inflammatory bowel disease
12/02/2004	US20040242618 Anticancer agents for prevention of cancer as agonist and antiandrogens
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242614 Pharmaceutically active compounds and methods of use thereof
12/02/2004	US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta
12/02/2004	US20040242609 Therapy for eating disorders, sexual disorders, psychological disorders
12/02/2004	US20040242604 Substituted heterocycles for the treatment of abnormal cell growth
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242498 CXCR3 antagonists
12/02/2004	CA2532059A1 Triaza-spiro compounds as nociceptin analogues and uses thereof
12/02/2004	CA2525507A1 Process for synthesizing .beta.-lactamase inhibitor intermediates
12/02/2004	CA2524948A1 Novel pyridopyrazines and use thereof as kinase inhibitors
12/01/2004	EP1482378A1 Electrophotographic organophotoreceptors with charge transport compounds
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481268A2 Nanofilm and membrane compositions
12/01/2004	EP1480979A2 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
12/01/2004	EP1480978A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
12/01/2004	EP1480977A2 Substituted aryl compounds for treatment of disease
12/01/2004	EP1480966A1 Compounds and methods of treating cell proliferative diseases
12/01/2004	EP1480644A2 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
12/01/2004	EP1480635A2 Macrocyclic module compositions

1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 646